Background: Assessment of antimicrobial use places an emphasis on therapeutic aspects of infected patients. Our aim was to determine the risk factors for unnecessary antibiotic therapy (UAT).

Methods: This was a prospective, multicenter study evaluating all curative antibiotic therapies prescribed over 2 consecutive days through the same electronic medical records. Each item that could participate in these prescriptions was collected from the computerized file (reason for hospitalization, comorbid conditions, suspected or definitive diagnosis of infection, microbial analyses). UAT was defined as the recognition of noninfectious sydromes (NIS), nonbacterial infections, use of redundant antimicrobials, and continuation of empirical broad-spectrum antimicrobials.

Results: Four hundred fifty-three antibiotic therapies were analyzed at 17 institutions. An infectious disease was the reason for hospitalization in 201 cases (44%). An unspecified diagnosis of infection was observed in 104 cases (23%). Microbial samples were taken in 296 cases (65%), allowing isolation of a pathogen in 156 cases (53%). Unspecified diagnosis was associated with the absence of a microbial sample compared to patients with a diagnosis: (56/104 [54%] vs 240/349 [69%]; P = .005). A total of 158 NIS were observed (35%). UAT was observed in 169 cases (37%), due to NIS in 106 cases. In multivariate analysis, the modifiable risk factors for UAT were unspecified diagnosis (adjusted odds ratio [AOR], 1.83; 95% confidence interval [CI], 1.04-3.20) and absence of a blood culture (AOR, 5.26; 95% CI, 2.56-10.00).

Conclusions: UAT is associated with an unspecified diagnosis and the absence of microbial testing. Antimicrobial stewardship programs should focus on diagnostic difficulties and microbial testing, the latter facilitating antibiotic reassessment and therapeutic interruption.

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy921DOI Listing

Publication Analysis

Top Keywords

unspecified diagnosis
16
risk factors
12
factors unnecessary
8
unnecessary antibiotic
8
antibiotic therapy
8
antibiotic therapies
8
reason hospitalization
8
diagnosis infection
8
absence microbial
8
microbial testing
8

Similar Publications

Background: Approximately 6.7 million Americans, aged 65 and older, are living with Alzheimer's disease (AD) dementia. Ethnoracial minority populations are at greater risk for AD.

View Article and Find Full Text PDF

Background: Chronic pain remains mostly untreated in those with Alzheimer's disease and related dementias (ADRD), mainly due to limited capacity to verbalize pain. Development of reliable objective biomarkers of chronic pain could improve pain assessment and treatment. We explored feasibility and acceptability of using a wearable electroencephalograph (EEG) and a screen-based eye tracker system to identify neural signatures of chronic pain in this population.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

PPD, Inc., Wilmington, NC, USA.

Background: Alzheimer's Disease and Related Dementias (ADRDs) patients have a well-established increase in comorbid disorders compared to non-cognitively impaired aged-matched controls. Since ADRDs are considered age-related disorders, it was hypothesized that younger ADRD patients should have a lower incidence of comorbid disorders than older ADRD patients.

Method: Four patient cohorts were defined in the TriNetX Analytics Network database (comprised of anonymized healthcare records from >150 million patients who have received care at 80+ health care organizations in the United States).

View Article and Find Full Text PDF

Background: The increasing incidence of cognitive impairment in older adults poses significant, complex challenges for patients and their families. While specialists have traditionally addressed this care, there is an urgent need to shift diagnosis and management of mild cognitive impairment (MCI) and dementia to primary care. The annual wellness visit for Medicare recipients provides an excellent opportunity for primary care providers (PCPs) to assess patients who may need a cognitive evaluation.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Background: Recent breakthroughs in the treatment of Alzheimer's Disease underscore the critical needs for early detection. In clinical settings, the diagnosis of Alzheimer's disease and related dementias (ADRD) is often delayed or overlooked, potentially missing critical opportunities for timely care and treatment. Cognitive symptoms can appear many years before the stage of dementia, potentially serving as a trigger for thorough cognitive assessments, which could prompt an early diagnosis of cognitive decline.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!